Trial intelligence / Profile preview

Estradiol for Vascular Function in Functional Hypothalamic Amenorrhea

NCT03018366Phase 2Completed

Sponsor
Cedars-Sinai Medical Center
Start
Jan 2017
Primary completion
Feb 2023
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol in Functional hypothalamic amenorrhea (FHA), sponsored by Cedars-Sinai Medical Center. Started Jan 2017; status: completed.

02

Drugs

estradiol
03

Conditions

Functional hypothalamic amenorrhea (FHA)

Beyond the preview

Go deeper on NCT03018366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03018366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call